199 related articles for article (PubMed ID: 8988202)
1. Definition of liver tumors in the presence of diffuse liver disease: comparison of findings at MR imaging with positive and negative contrast agents.
Kuwatsuru R; Brasch RC; Mühler A; Mathur A; Vexler VS; Rosenau W; Mintorovitch J; Berthezene Y; Cohen F; Shames DM
Radiology; 1997 Jan; 202(1):131-8. PubMed ID: 8988202
[TBL] [Abstract][Full Text] [Related]
2. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of radiation-induced liver injury with MR imaging: comparison of hepatocellular and reticuloendothelial contrast agents.
Clément O; Mühler A; Vexler VS; Rosenau W; Berthezène Y; Kuwatsuru R; Brasch RC
Radiology; 1992 Oct; 185(1):163-8. PubMed ID: 1523301
[TBL] [Abstract][Full Text] [Related]
4. Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions.
Vogl TJ; Hammerstingl R; Schwarz W; Mack MG; Müller PK; Pegios W; Keck H; Eibl-Eibesfeldt A; Hoelzl J; Woessmer B; Bergman C; Felix R
Radiology; 1996 Mar; 198(3):881-7. PubMed ID: 8628887
[TBL] [Abstract][Full Text] [Related]
5. Detection of hepatocellular carcinoma by ferumoxides-enhanced MR imaging in cirrhosis: Incremental value of dynamic gadolinium-enhancement.
Qayyum A; Thoeni RF; Coakley FV; Lu Y; Guay JP; Ferrell LD
J Magn Reson Imaging; 2006 Jan; 23(1):17-22. PubMed ID: 16315209
[TBL] [Abstract][Full Text] [Related]
6. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number.
Lim JH; Choi D; Cho SK; Kim SH; Lee WJ; Lim HK; Park CK; Paik SW; Kim YI
Radiology; 2001 Sep; 220(3):669-76. PubMed ID: 11526265
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte-targeted MR contrast agents: contrast enhanced detection of liver cancer in diffusely damaged liver.
Tanimoto A; Kuribayashi S
Magn Reson Med Sci; 2005; 4(2):53-60. PubMed ID: 16340158
[TBL] [Abstract][Full Text] [Related]
8. Detection of focal liver lesions: CT of the hepatobiliary system with gadoxetic acid disodium, or Gd-EOB-DTPA.
Schmitz SA; Häberle JH; Balzer T; Shamsi K; Boese-Landgraf J; Wolf KJ
Radiology; 1997 Feb; 202(2):399-405. PubMed ID: 9015065
[TBL] [Abstract][Full Text] [Related]
9. Acute liver rejection: evaluation with cell-directed MR contrast agents in a rat transplantation model.
Mühler A; Freise CE; Kuwatsuru R; Rosenau W; Liu T; Mintorovitch J; Clement O; Vexler V; Mahboubi S; Lang P
Radiology; 1993 Jan; 186(1):139-46. PubMed ID: 8416555
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of liver-specific MRI contrast agents in rats with hepatitis and cirrhosis.
Kato N; Takahashi M; Ihara S; Tsujimoto T; Miyazawa T
Acad Radiol; 1998 Apr; 5 Suppl 1():S83-5. PubMed ID: 9561051
[No Abstract] [Full Text] [Related]
11. A prototype liver-specific contrast medium for CT: preclinical evaluation of gadoxetic acid disodium, or Gd-EOB-DTPA.
Schmitz SA; Wagner S; Schuhmann-Giampieri G; Krause W; Wolf KJ
Radiology; 1997 Feb; 202(2):407-12. PubMed ID: 9015066
[TBL] [Abstract][Full Text] [Related]
12. [New MR contrast media in liver diagnosis. Initial clinical results with hepatobiliary Eovist (gadolinium-EOB-DTPA) and RES-specific Resovist (SH U 555 A)].
Reimer P; Tombach B; Daldrup H; Hesse T; Sander G; Balzer T; Shamsi K; Berns T; Rummeny EJ; Peters PE
Radiologe; 1996 Feb; 36(2):124-33. PubMed ID: 8867429
[TBL] [Abstract][Full Text] [Related]
13. Functional hepatobiliary imaging with gadolinium-EOB-DTPA. A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats.
Schmitz SA; Mühler A; Wagner S; Wolf KJ
Invest Radiol; 1996 Mar; 31(3):154-60. PubMed ID: 8675423
[TBL] [Abstract][Full Text] [Related]
14. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions.
Ros PR; Freeny PC; Harms SE; Seltzer SE; Davis PL; Chan TW; Stillman AE; Muroff LR; Runge VM; Nissenbaum MA
Radiology; 1995 Aug; 196(2):481-8. PubMed ID: 7617864
[TBL] [Abstract][Full Text] [Related]
15. Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
Mühler A; Clément O; Vexler V; Berthezène Y; Rosenau W; Brasch RC
Radiology; 1992 Jul; 184(1):207-13. PubMed ID: 1609081
[TBL] [Abstract][Full Text] [Related]
16. Contrast enhancement with Gd-EOB-DTPA in MR imaging of hepatocellular carcinoma in mice: a comparison with superparamagnetic iron oxide.
Fujita M; Yamamoto R; Fritz-Zieroth B; Yamanaka T; Takahashi M; Miyazawa T; Tatsuta M; Terada N; Hosomi N; Inoue E; Kuroda C
J Magn Reson Imaging; 1996; 6(3):472-7. PubMed ID: 8724413
[TBL] [Abstract][Full Text] [Related]
17. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
18. Liver tumors in cirrhosis: experimental study with SPIO-enhanced MR imaging.
Clement O; Frija G; Chambon C; Schouman-Clayes E; Mosnier JF; Poupon MF; Balkau B
Radiology; 1991 Jul; 180(1):31-6. PubMed ID: 2052718
[TBL] [Abstract][Full Text] [Related]
19. Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi--gadoxetic acid-enhanced MR imaging.
Tsuda N; Matsui O
Radiology; 2010 Sep; 256(3):767-73. PubMed ID: 20663976
[TBL] [Abstract][Full Text] [Related]
20. Nondiffuse fatty change of the liver: discerning pseudotumor on MR images enhanced with ferumoxides-initial observations.
Hirohashi S; Ueda K; Uchida H; Ono W; Takahama J; Takewa M; Kitano S; Ohishi H
Radiology; 2000 Nov; 217(2):415-20. PubMed ID: 11058637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
